about
Systematic review with meta-analysis: the association between the use of calcium channel blockers and gastrointestinal bleedingEfficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis.Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six CountriesCost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses.Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials.Adverse drug reactions - examples of detection of rare events using databases.Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis.Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries.Association between oral fluoroquinolones and seizures: A self-controlled case series studyMedication safety research by observational study design.The association between non-vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta-analysis of observational studies.Efficacy and safety of lorcaserin in obese adults: a meta-analysis of 1-year randomized controlled trials (RCTs) and narrative review on short-term RCTs.The phenomenon of micronutrient deficiency among children in China: a systematic review of the literature.Association between oral fluoroquinolone use and the development of retinal detachment: a systematic review and meta-analysis of observational studies.Cardiovascular outcomes associated with use of clarithromycin: population based study.Association of Risk of Suicide Attempts With Methylphenidate Treatment.Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groups.The impact of ischaemic stroke on atrial fibrillation-related healthcare cost: a systematic review.Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation.Management of acute agitation in Hong Kong and comparisons with Australasia.Safety profiles of iron chelators in young patients with haemoglobinopathies.Improving medication safety and diabetes management in Hong Kong: a multidisciplinary approach.Methylphenidate and the risk of trauma.Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment.Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis.Association Between Acute Neuropsychiatric Events and Helicobacter pylori Therapy Containing Clarithromycin.Variation in the management of hypothetical cases of acute agitation in Australasian emergency departments.Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.Dosage effects of histamine-2 receptor antagonist on the primary prophylaxis of non-steroidal anti-inflammatory drug (NSAID)-associated peptic ulcers: a retrospective cohort study.ADHD Drug Prescribing Trend Is Increasing Among Children and Adolescents in Hong Kong.Intravenous olanzapine--another option for the acutely agitated patient?Midazolam-Droperidol, Droperidol, or Olanzapine for Acute Agitation: A Randomized Clinical Trial.Effectiveness of Pharmacological Treatment for Attention-Deficit/Hyperactivity Disorder on Physical Injuries: A Systematic Review and Meta-Analysis of Observational Studies.Intravenous midazolam-droperidol combination, droperidol or olanzapine monotherapy for methamphetamine-related acute agitation: subgroup analysis of a randomized controlled trial.Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.Neuropsychiatric Events Associated with Leukotriene-Modifying Agents: A Systematic Review.Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study.Chinese Health Literacy Scale for Diabetes - multiple-choice version (CHLSD-MC): a validation study.Economic Evaluation of Midazolam-Droperidol Combination, Versus Droperidol or Olanzapine for the Management of Acute Agitation in the Emergency Department: A Within-Trial Analysis.Bleeding-related hospital admissions and 30-day readmissions in patients with non-valvular atrial fibrillation treated with dabigatran versus warfarin.
P50
Q28081521-C33AE12F-2F44-420E-8130-C2F75A431DC6Q35020811-415054F9-1003-4D89-9DB2-4FA552CBA089Q36034337-54925B0D-E0CE-4C51-9F02-0E0007E63D00Q36064839-C3449AE2-914D-48F4-96F7-6E5CC778EC93Q36109823-CBFBD66D-AA78-4F3F-B9C1-513664B5A0BBQ36125541-3A313360-5945-4A9D-90E5-07A49E5ED2B6Q36342810-A5B0EC51-037F-4FCB-96B5-B46FA77F3B4CQ36402633-B61D4D72-D843-431F-B889-8664922BAD2BQ36862757-D2812776-A14B-482F-91DA-80C4189F4625Q37009536-76140643-9BDA-4863-9C15-C7ECD528D395Q37030683-CD4F5702-E031-4B2E-AD7E-AAF31F2C50CEQ38075153-C1E6BFA9-7898-4A3C-A29C-FBCFCF8B78AEQ38253499-0C85EE2C-0A42-4C14-8746-FFB251FA2060Q38294391-1CC02F7A-6651-4F74-9132-8E69EECFD1F5Q38410307-9B886B46-4ECB-48B0-99C5-E393C6140625Q38659993-8CE526BE-C893-49AC-B864-C92FCB829593Q38700601-F5A2CE10-34A8-41C1-A84A-44E90040E57AQ38840977-F5BE7ECF-0097-4E64-8CA0-02FA26004AE6Q38890093-3F76C3C0-5FA4-4687-94C3-97B38A32BE20Q38935501-79330422-235B-491B-AF14-904F3D5AD4A1Q39022073-E07B23D3-586E-48CC-A683-FE9695BD69D5Q39182886-45F14724-F688-4E6C-A87D-255514CD4CD0Q39209210-8101AB7A-900D-45C2-BF99-8BE84DB63AA4Q39229424-914671B0-CACD-43A4-867F-4466DB074C74Q39373841-951FEF3D-A139-47DA-9B33-F4AC1D9E3452Q39802868-D4B4FA18-E366-4F61-AF38-4BCB0AE5F7ADQ39815254-B664D841-CBB0-452F-A81D-A413DFF5CDF9Q41748789-C9C0C172-DB0A-4D99-8549-C4C07516ED03Q44452482-F5E40C5F-8DA9-44D7-B818-58BED98CEFF1Q45176341-F184E8DF-B046-4EDE-8A8A-4228CE630BE3Q45968773-99F9BE8D-66CE-4D2A-909A-F127EB1F20F6Q47378659-2CF34E2F-523B-4BEE-A2E3-D3318730EAD2Q47572710-8E30725B-1CFE-43B4-8FE8-2EDF9BFEE9A4Q48276804-87E282B2-6F97-4B2E-8938-92CF5D460541Q48833682-9CA64407-E193-4B9C-841E-9499EE8CA774Q50093929-6F0573F9-A0B7-4872-957D-C5201B447521Q51759180-EE1396D6-5493-411A-89FB-2304C36F30D8Q52152037-3CF4E190-9FD0-4719-8CCE-F80A9075D92CQ52603252-1D9D4E1C-8BA2-4245-8958-B4F9C3920285Q53140080-9DC8F75E-8CDA-4607-96CE-CCAF9245506F
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Esther W Chan
@en
Esther W Chan
@nl
type
label
Esther W Chan
@en
Esther W Chan
@nl
prefLabel
Esther W Chan
@en
Esther W Chan
@nl
P31
P496
0000-0002-7602-9470